The first affiliated hospital of medical college of zhejiang university
The first affiliated hospital of medical college of zhejiang university
Hangzhou, Zhejiang, China13 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Clinical Study of SYNCAR-100 in the Treatment of Relapsed/Refractory Acute B-Lymphoblastic Leukemia | B-cell acute lymphoblastic leukemia, B-cell neoplasm, Burkitt lymphoma, DNA Virus Infections, Epstein-Barr virus infection, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Infections, Neoplasms by Histologic Type, Tumor Virus Infections, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, viral infectious disease | Recruiting | Early phase 1 | 2026-02-24 | NCT07429461 | |
| IL-5 CAR-T Cell Therapy for Refractory/Relapsed Eosinophilic Leukemia | Hemic and Lymphatic Diseases, hematologic disorder, neoplasm | Recruiting | Phase 1 | 2025-12-10 | NCT07257640 | |
| A Multicenter Study of CAR-T Cells in Primary Ph+All | acute lymphoblastic leukemia | Recruiting | Phase 2 | 2025-12-04 | NCT07252336 | |
| Donor Derived CD117 CAR-T Cells in the Treatment of R/R Acute Myeloid Leukemia | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Early phase 1 | 2025-08-27 | NCT07144020 | |
| CD7 CAR-T Bridging to alloHSCT for R/R CD7+Malignant Hematologic Diseases | Hemic and Lymphatic Diseases, hematologic disorder, neoplasm | Recruiting | Phase 1 / Phase 2 | 2025-08-13 | NCT05827835 | |
| Donor Derived CD19 CAR-T Cells in the Treatment of R/R B-cell Acute Lymphoblastic Leukemia | B-cell acute lymphoblastic leukemia, B-cell neoplasm, Burkitt lymphoma, DNA Virus Infections, Epstein-Barr virus infection, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Infections, Neoplasms by Histologic Type, Tumor Virus Infections, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, viral infectious disease | Recruiting | Early phase 1 | 2025-01-27 | NCT06793241 | |
| CD7 CAR-T Cell Sequential Allo-HSCT for Non-malignant Blood and Immune System Diseases | Bone Marrow Failure Disorders, Hemic and Lymphatic Diseases, bone marrow disorder, hematologic disorder | Recruiting | Early phase 1 | 2025-01-22 | NCT06787560 | |
| CD19/BCMA CAR-T Cell Therapy for Refractory/Relapsed Lupus Nephritis | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Skin and Connective Tissue Diseases, Urogenital Diseases, autoimmune disease, connective tissue disorder, glomerulonephritis, immune system disorder, kidney disorder, lupus nephritis, nephritis, systemic lupus erythematosus, urinary system disorder | Recruiting | Early phase 1 | 2025-01-21 | NCT06785519 | |
| Clinical Study on the Safety and Efficacy of CD7 CAR-T Cell Sequential Allo-HSCT and Kidney Transplantation in the Treatment of SIOD | Schimke immuno-osseous dysplasia | Recruiting | Early phase 1 | 2025-01-20 | NCT06769191 | |
| A Clinical Study to Explore the Safety and Efficacy of CD33 CAR-T Cell in Relapsed/Refractory Acute Myeloid Leukemia | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Early phase 1 | 2025-01-07 | NCT06762132 | |
| Targeting CD5 CAR-T Cells in the Treatment of r/r CD5+ T-ALL | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm | Recruiting | Early phase 1 | 2024-10-09 | NCT06633354 | |
| Targeting CD5 CAR-T Cells in the Treatment of r/r CD5+ T-lymphoma | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, T-lymphoblastic lymphoma, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm | Recruiting | Early phase 1 | 2024-10-09 | NCT06633341 | |
| CD 70 CAR T for Patients With CD70 Positive Malignant Hematologic Diseases | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, monoclonal gammopathy, myeloid leukemia, neoplasm, non-Hodgkin lymphoma, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Recruiting | Early phase 1 | 2021-11-04 | NCT04662294 |